BIIB022
Product Specifications
Target
IGF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
BIIB022 is a human IgG4 monoclonal antibody (mAb) targeting IGF1R/CD221. It inhibits the phosphorylation of IGF-1 and IGF-2-induced IGF-1R and its downstream substrates. BIIB022 is applicable for research in lung cancer, pancreatic cancer, and colon cancer. The recommended isotype control is Human IgG4 kappa, Isotype Control.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/390881189076451404/T9901A-1649
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1120754-01 0.02 mg (E-Coli)
Recombinant Citrobacter koseri Adenylosuccinate synthetase (purA)
Ask
View Details MBS1120754-02 0.02 mg (Yeast)
Recombinant Citrobacter koseri Adenylosuccinate synthetase (purA)
Ask
View Details 
MBS1120754-03 0.1 mg (E-Coli)
Recombinant Citrobacter koseri Adenylosuccinate synthetase (purA)
Ask
View Details 
MBS1120754-04 0.1 mg (Yeast)
Recombinant Citrobacter koseri Adenylosuccinate synthetase (purA)
Ask
View Details MBS1120754-05 0.02 mg (Baculovirus)
Recombinant Citrobacter koseri Adenylosuccinate synthetase (purA)
Ask
View Details